(PDF) Effectiveness and Safety of Targeted Drugs for the

Effectiveness and Safety of Targeted Drugs for the Treatment of Adults With Moderate-To-Severe Plaque Psoriasis in the Russian Federation

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)

doi 10.31556/2219-0678.2019.38.4.076-086

Full Text

Abstract

Available in full text

Date

December 1, 2019

Authors

Daria Georgievna Tolkacheva

Valeria Dmitrievna Sokolova

Vladimir Valentinovich Mladov

Publisher

Fund Gelios

Related search

Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece

Value in Health

Occupational Health

English

Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis

Archives of Dermatology

English

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

JAMA Dermatology

English

Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-To-Severe Plaque Psoriasis in Italy

Global and Regional Health Technology Assessment

English

Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis

British Journal of Dermatology

English

Pss30 - Cost Effectiveness of Dimethyl Fumarate (Dmf) in the Treatment of Moderate to Severe Plaque Psoriasis: A Uk Perspective

Value in Health

Occupational Health

English

The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis

Journal of Dermatological Treatment

English

New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis

Pharmacogenomics Journal

Molecular Medicine

English

Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis

Biopharmaceutics and Drug Disposition

Pharmaceutical Science

English